INKT
Mink Therapeutics Inc
12.30$
+1.2%
vs. previous close
Closing price · As of: Sep 29, 2026
Statements
Cash Flow
Mink Therapeutics Inc (INKT) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Operating Cash Flow" came in at -5.9 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
Tick rows to compare them in a chart (up to 4)
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| -15 | -8.3 | -13 | -19 | -16 | -9.6 | -5.9 | |
| 0.0 | 0.1 | 0.1 | 0.1 | 0.2 | 0.2 | 0.2 | |
| 0.2 | 0.1 | 1.7 | 3.0 | 3.9 | 1.8 | 2.7 | |
| 1.3 | 6.4 | 14 | 3.0 | – | – | – | |
| 4.1 | -0.3 | 3.7 | 8.8 | 2.9 | 0.5 | 3.3 | |
| 0.4 | 0.1 | 0.2 | 0.3 | 0.1 | 0.0 | 0.0 | |
| -0.4 | -0.1 | -0.2 | -0.3 | -0.1 | – | – | |
| – | – | 0.0 | -0.2 | -0.5 | 0.0 | – | |
| 11 | 11 | 9.5 | 0.0 | 0.0 | 5.0 | 0.0 | |
| 11 | 11 | 49 | -0.2 | -0.4 | 11 | 15 | |
| -4.1 | 2.4 | 36 | -19 | -16 | 1.2 | 8.8 | |
| -15 | -8.4 | -13 | -19 | -16 | -9.6 | -5.9 |
Data as of: September 29, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.